389 related articles for article (PubMed ID: 11180501)
1. Injections of an opioid antagonist into the locus coeruleus and periaqueductal gray but not the amygdala precipitates morphine withdrawal in the 7-day-old rat.
Jones KL; Barr GA
Synapse; 2001 Feb; 39(2):139-51. PubMed ID: 11180501
[TBL] [Abstract][Full Text] [Related]
2. Opposite modulation of opiate withdrawal behaviors on microinfusion of a protein kinase A inhibitor versus activator into the locus coeruleus or periaqueductal gray.
Punch LJ; Self DW; Nestler EJ; Taylor JR
J Neurosci; 1997 Nov; 17(21):8520-7. PubMed ID: 9334424
[TBL] [Abstract][Full Text] [Related]
3. Role of different brain structures in the expression of the physical morphine withdrawal syndrome.
Maldonado R; Stinus L; Gold LH; Koob GF
J Pharmacol Exp Ther; 1992 May; 261(2):669-77. PubMed ID: 1578378
[TBL] [Abstract][Full Text] [Related]
4. Double dissociation in the neural substrates of acute opiate dependence as measured by withdrawal-potentiated startle.
Harris AC; Atkinson DM; Aase DM; Gewirtz JC
Neuroscience; 2006; 139(4):1201-10. PubMed ID: 16600512
[TBL] [Abstract][Full Text] [Related]
5. Cerebral glucose metabolism during opioid withdrawal following methylnaloxonium injection into the locus coeruleus.
Kimes AS; Maldonado R; Ambrosio E; Koob GF; London ED
Brain Res; 1998 Dec; 814(1-2):1-12. PubMed ID: 9838021
[TBL] [Abstract][Full Text] [Related]
6. The primate locus coeruleus and effects of clonidine on opiate withdrawal.
Redmond DE; Huang YH
J Clin Psychiatry; 1982 Jun; 43(6 Pt 2):25-9. PubMed ID: 6282817
[TBL] [Abstract][Full Text] [Related]
7. Antagonism of orexin type 1 receptors in the locus coeruleus attenuates signs of naloxone-precipitated morphine withdrawal in rats.
Azizi H; Mirnajafi-Zadeh J; Rohampour K; Semnanian S
Neurosci Lett; 2010 Oct; 482(3):255-9. PubMed ID: 20667500
[TBL] [Abstract][Full Text] [Related]
8. Involvement of the bed nucleus of the stria terminalis activated by the central nucleus of the amygdala in the negative affective component of morphine withdrawal in rats.
Nakagawa T; Yamamoto R; Fujio M; Suzuki Y; Minami M; Satoh M; Kaneko S
Neuroscience; 2005; 134(1):9-19. PubMed ID: 15939543
[TBL] [Abstract][Full Text] [Related]
9. Anxiety-like symptoms induced by morphine withdrawal may be due to the sensitization of the dorsal periaqueductal grey.
Castilho VM; Borelli KG; Brandão ML; Nobre MJ
Physiol Behav; 2008 Jul; 94(4):552-62. PubMed ID: 18485423
[TBL] [Abstract][Full Text] [Related]
10. Elevated mu-opioid receptor expression in the nucleus of the solitary tract accompanies attenuated withdrawal signs after chronic low dose naltrexone in opiate-dependent rats.
Van Bockstaele EJ; Rudoy C; Mannelli P; Oropeza V; Qian Y
J Neurosci Res; 2006 Feb; 83(3):508-14. PubMed ID: 16385558
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of morphine withdrawal by the NMDA receptor antagonist MK-801 in rat is age-dependent.
Zhu H; Barr GA
Synapse; 2001 Jun; 40(4):282-93. PubMed ID: 11309844
[TBL] [Abstract][Full Text] [Related]
12. Expression of c-Fos in the rat central amygdala accompanies the acquisition but not expression of conditioned place aversion induced by withdrawal from acute morphine dependence.
Jin C; Araki H; Nagata M; Shimosaka R; Shibata K; Suemaru K; Kawasaki H; Gomita Y
Behav Brain Res; 2005 Jun; 161(1):107-12. PubMed ID: 15904717
[TBL] [Abstract][Full Text] [Related]
13. A comparison of the effects of clonidine and CNQX infusion into the locus coeruleus and the amygdala on naloxone-precipitated opiate withdrawal in the rat.
Taylor JR; Punch LJ; Elsworth JD
Psychopharmacology (Berl); 1998 Jul; 138(2):133-42. PubMed ID: 9718282
[TBL] [Abstract][Full Text] [Related]
14. Chronic very low dose naltrexone administration attenuates opioid withdrawal expression.
Mannelli P; Gottheil E; Peoples JF; Oropeza VC; Van Bockstaele EJ
Biol Psychiatry; 2004 Aug; 56(4):261-8. PubMed ID: 15312814
[TBL] [Abstract][Full Text] [Related]
15. Lack of neuropeptide Y attenuates the somatic signs of opiate withdrawal.
Olson VG; Griner NB; Heusner CL; Palmiter RD
Synapse; 2006 Dec; 60(7):553-6. PubMed ID: 16952158
[TBL] [Abstract][Full Text] [Related]
16. Endorphin-locus coeruleus connection mediates opiate action and withdrawal.
Gold MS; Byck R; Sweeney DR; Kleber HD
Biomedicine; 1979 Feb; 30(1):1-4. PubMed ID: 223678
[TBL] [Abstract][Full Text] [Related]
17. A novel action of morphine in the rat locus coeruleus: persistent decrease in adenylate cyclase.
Beitner DB; Duman RS; Nestler EJ
Mol Pharmacol; 1989 May; 35(5):559-64. PubMed ID: 2498635
[TBL] [Abstract][Full Text] [Related]
18. Ventral pallidal injections of a mu antagonist block the development of behavioral sensitization to systemic morphine.
Johnson PI; Napier TC
Synapse; 2000 Oct; 38(1):61-70. PubMed ID: 10941141
[TBL] [Abstract][Full Text] [Related]
19. Attenuation of morphine withdrawal signs by intracerebral administration of 18-methoxycoronaridine.
Panchal V; Taraschenko OD; Maisonneuve IM; Glick SD
Eur J Pharmacol; 2005 Nov; 525(1-3):98-104. PubMed ID: 16289028
[TBL] [Abstract][Full Text] [Related]
20. Acute opioid physical dependence in postaddict humans: naloxone dose effects after brief morphine exposure.
Heishman SJ; Stitzer ML; Bigelow GE; Liebson IA
J Pharmacol Exp Ther; 1989 Jan; 248(1):127-34. PubMed ID: 2913267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
